Global Biomaterials Market Size, Growth, Opportunity and Forecast

  • Product Code:
    RP-ID-10008416
  • Published Date:
    24 Feb 2020
  • Region:
    Global
  • Pages:
    144
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-12

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

The global BiomaterialsMarketwas valued at USD 70.86 billion in 2016 and is projected to reach USD 267.19 billion by 2025, growing at a CAGR of 15.89% from 2017 to 2025.
A biomaterial is any substance that has been engineered to interact with biological systems for a medical purpose - either a therapeutic (treat, augment, repair or replace a tissue function of the body) or a diagnostic one.

Sample Infographics:



Market Dynamics:
1. Market Drivers
1.1 Increased Funds and Grants By Government Bodies for the Development of Novel Biomaterials
1.2 Increasing Demand for Implantable Devices
1.3 Growing Demand for Biomaterials in Plastic Surgery and Wound Healing Applications
1.4 Rising Number of Hip and Knee Replacement Procedures
1.5 Rising Geriatric Population and Subsequent Increase in Incidences of Cardiovascular Diseases
1.6 Increasing Awareness About Regenerative Medicine

2. Market Restraints
2.1 Stringent Clinical & Regulatory Processes
2.2 Unfavorable Healthcare Reforms in the U.S.
Market Segmentation:
1. Global Biomaterials Market, by Application:
1.1 Ophthalmology
1.2 Dental
1.3 Plastic Surgery
1.4 Wound Healing
1.5 Tissue Engineering
1.6 Neurological/Central Nervous System
1.7 Orthopedic
1.8 Cardiovascular
1.9 Other Applications

2. Global Biomaterials Market, by Type Of Material:
2.1 Metallic Biomaterials
2.2 Ceramics
2.3 Polymers
2.4 Natural Biomaterials

3. Global Biomaterials Market, by Region:
3.1 North America (U.S., Canada, Mexico)
3.2 Europe (Germany, UK, France, Rest of Europe)
3.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
3.4 Latin America (Brazil, Argentina, Rest of Latin America)
3.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Royal DSM
2. BASF SE
3. Corbion N.V.
4. Covestro (Subsidiary of Bayer AG)
5. Invibio Ltd. (Subsidiary of Victrex PLC)
6. Carpenter Technology Corporation
7. Evonik Industries AG
8. Berkeley Advanced Biomaterails, Inc.
9. Cam BioceramicsBv
10. Celanese Corporation
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the BiomaterialsMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL BIOMATERIALSMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL BIOMATERIALSMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL BIOMATERIALS MARKET, BY APPLICATION
5.1 Ophthalmology
5.2 Dental
5.3 Plastic Surgery
5.4 Wound Healing
5.5 Tissue Engineering
5.6 Neurological/Central Nervous System
5.7 Orthopedic
5.8 Cardiovascular
5.9 Other Applications

6 GLOBAL BIOMATERIALS MARKET, BY TYPE OF MATERIAL
6.1 Metallic Biomaterials
6.2 Ceramics
6.3 Polymers
6.4 Natural Biomaterials

7 GLOBAL BIOMATERIALSMARKET, BY GEOGRAPHY
7.1 Overview
7.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest of Europe
7.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
7.5.1 Brazil
7.5.2 Argentina
7.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 – 2025

8 GLOBAL BIOMATERIALSMARKETCOMPETITIVE LANDSCAPE
8.1 Overview
8.2 Company Market Share
8.3 Vendor Landscape
8.4 Key Development Strategies

9 COMPANY PROFILES
9.1 Royal DSM
9.1.1 Overview
9.1.2 Financial Performance
9.1.3 Product Outlook
9.1.4 Key Developments

9.2 BASF SE
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments

9.3 Corbion N.V.
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments

9.4 Covestro (Subsidiary of Bayer AG)
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments

9.5 Invibio Ltd. (Subsidiary of Victrex PLC)
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments

9.6 Carpenter Technology Corporation
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Developments

9.7 Evonik Industries AG
9.7.1 Overview
9.7.2 Financial Performance
9.7.3 Product Outlook
9.7.4 Key Developments

9.8 Berkeley Advanced Biomaterails, Inc.
9.8.1 Overview
9.8.2 Financial Performance
9.8.3 Product Outlook
9.8.4 Key Developments

9.9 Cam BioceramicsBv
9.9.1 Overview
9.9.2 Financial Performance
9.9.3 Product Outlook
9.9.4 Key Developments

9.10 Celanese Corporation
9.10.1 Overview
9.10.2 Financial Performance
9.10.3 Product Outlook
9.10.4 Key Developments

10 Appendix
10.1 Related Reports
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
1. Royal DSM
2. BASF SE
3. Corbion N.V.
4. Covestro (Subsidiary of Bayer AG)
5. Invibio Ltd. (Subsidiary of Victrex PLC)
6. Carpenter Technology Corporation
7. Evonik Industries AG
8. Berkeley Advanced Biomaterails, Inc.
9. Cam BioceramicsBv
10. Celanese Corporation
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports